Cargando…

Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities

There are important breakthroughs in the treatment of paediatric acute lymphoblastic leukaemia (ALL) since 1950, by which the prognosis of the child majority suffered from ALL has been improved. However, there are urgent needs to have disease-specific biomarkers to monitor the therapeutic efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	López Villar, Elena, Wu, Duojiao, Cho, William C, Madero, Luis, Wang, Xiangdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124009/ https://www.ncbi.nlm.nih.gov/pubmed/24912534 http://dx.doi.org/10.1111/jcmm.12319

Ejemplares similares

Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
por: López Villar, Elena, et al.
Publicado: (2015)

The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy
por: Grobbelaar, Carle, et al.
Publicado: (2019)

Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)

Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
por: Kourti, Maria, et al.
Publicado: (2023)

Prediction of leukocyte counts during paediatric acute lymphoblastic leukaemia maintenance therapy
por: Karppinen, Santeri, et al.
Publicado: (2019)

Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study
por: Hahn, Seung Min, et al.
Publicado: (2022)

The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
por: Chulián, Salvador, et al.
Publicado: (2023)

Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression
por: Toscan, Cara E., et al.
Publicado: (2020)

Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
por: Sallam, Reem M.
Publicado: (2015)

Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2015)

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
por: Venn, Nicola C., et al.
Publicado: (2022)

Superior mediastinal syndrome in paediatric B-cell acute lymphoblastic leukaemia: a case report
por: Rahat-Ul-Ain,, et al.
Publicado: (2022)

Overweight and obesity management strategies in survivors of paediatric acute lymphoblastic leukaemia: a systematic review protocol
por: Ladhani, Salma, et al.
Publicado: (2018)

Blinatumomab as bridging therapy in paediatric B‐cell acute lymphoblastic leukaemia complicated by invasive fungal disease
por: Yeoh, Daniel K., et al.
Publicado: (2022)

Paediatric pre‐B acute lymphoblastic leukaemia‐derived exosomes regulate immune function in human T cells
por: Gholipour, Elham, et al.
Publicado: (2022)

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia
por: Villa-Morales, María, et al.
Publicado: (2023)

TYK2 Variants in B-Acute Lymphoblastic Leukaemia
por: Turrubiartes-Martínez, Edgar, et al.
Publicado: (2020)

T lymphoblastic leukaemia and the central nervous system.
por: Lilleyman, J. S., et al.
Publicado: (1981)

Long survival in childhood lymphoblastic leukaemia.
por: Chessells, J. M., et al.
Publicado: (1987)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia
por: Da Costa, D, et al.
Publicado: (2013)

Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia
por: Lu, Y, et al.
Publicado: (2014)

Low spontaneous apoptosis index at diagnosis predicts a high-risk phenotype in paediatric acute lymphoblastic leukaemia
por: Singh, Ankita, et al.
Publicado: (2018)

An information-theory analysis of DNA methylation identifies converging genetic and epigenetic drivers of paediatric acute lymphoblastic leukaemia
por: Koldobskiy, Michael A., et al.
Publicado: (2021)

Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B‐precursor acute lymphoblastic leukaemia
por: Huang, Qingsheng, et al.
Publicado: (2021)

Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia
por: Ben Hassine, Khalil, et al.
Publicado: (2021)

“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
por: Matthews, Holly, et al.
Publicado: (2016)

The Proteomics Big Challenge for Biomarkers and New Drug-Targets Discovery
por: Savino, Rocco, et al.
Publicado: (2012)

Impact of mTOR expression on clinical outcome in paediatric patients with B-cell acute lymphoblastic leukaemia – preliminary report
por: Ulińska, Edyta, et al.
Publicado: (2016)

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia
por: Foley, Bree, et al.
Publicado: (2020)

Paediatric acute lymphoblastic leukaemia and caesarean section: A report from the United Kingdom Childhood Cancer Study (UKCCS)
por: Bonaventure, Audrey, et al.
Publicado: (2020)

Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis
por: Margolis, Elisa B, et al.
Publicado: (2021)

Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions
por: Hoeben, Bianca A. W., et al.
Publicado: (2021)

Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single‐centre cohort
por: Brivio, Erica, et al.
Publicado: (2022)

Changes in Nutritional Status during Induction Phase and Their Association with Fever and Minimal Residual Disease in Paediatric Acute Lymphoblastic Leukaemia
por: Gustaitė, Sigita, et al.
Publicado: (2023)

PB1751: RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (R/R ALL) IN A SINGLE-CENTRE PAEDIATRIC POPULATION
por: Gomes, Guadalupe Ferreira, et al.
Publicado: (2023)

Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia
por: Moreira-Nunes, Caroline Aquino, et al.
Publicado: (2020)

Bony Lesions in Paediatric Acute Leukaemia
por: Saveyn, Thiebault, et al.
Publicado: (2021)

Effect of Aplidin in acute lymphoblastic leukaemia cells
por: Erba, E, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_7torfa2070jj39s2ltid84lhnb